Interestingly, both mRNA and serum insulin levels in T1DM mice were significantly enhanced after 8-day treatment with empagliflozin, which might be due to the preservation of β-cell mass, as evidenced by the reduction of β-cell apoptosis as well as the stimulation of β-cell proliferation in the present study. This evidence concerns the gene INS and type 1 diabetes mellitus.